Table 3.

OR and 95% CI between hyperuricaemia and AF prevalence

Group	Subjects (n)	AF	Prevalence (%)	Unadjusted model		Adjusted model
				OR (95% CI)	P value	OR (95% CI)	P value
Men*	4686	35	0.74
Normal SUA level	3844	29	0.75	1.000	1.0000	1.000	1.0000
Hyperuricaemia	842	6	0.71	0.944 (0.391 to 2.281)	0.90	1.025 (0.400 to 2.626)	0.96
Women*	4251	18	0.42
Normal SUA level	3896	11	0.28	1.000	1.0000	1.000	1.0000
Hyperuricaemia	355	7	1.97	7.104 (2.737 to 18.442)	<0.001	6.366 (2.553 to 15.871)	<0.001
Total †	8937	53	0.60
Normal SUA level	7740	40	0.52	1.000	1.0000	1.000	1.0000
Hyperuricaemia	1197	13	1.09	2.114 (1.128 to 3.964)	0.02	2.051 (1.063 to 3.856)	0.03
Sensitive analysis
Total ‡
Normal SUA level	5525	17	0.31	1.000	1.0000	1.000	1.0000
Hyperuricaemia	635	9	1.42	4.658 (2.068 to 10.494)	<0.001	5.666 (2.383 to 13.473)	<0.001
Total §
Normal SUA level	7699	37	0.48	1.000	1.0000	1.000	1.0000
Hyperuricaemia	1191	13	1.09	2.285 (1.211 to 4.312)	0.01	2.183 (1.132 to 4.212)	0.02

*Model 1: adjusted for age, smoking, alcohol use, diuretics use, statins use, hypertension, diabetes, MI, TIA/stroke and dyslipidaemia, heart failure and gout.

†Model 2: adjusted for model 1 and sex.

‡Model 3: adjusted for model 2 and further excluded subjects with hypertension.

§Model 4: adjusted for model 2 and further excluded subjects with MI or heart failure.

AF, atrial fibrillation; MI, myocardial infarction; SUA, serum uric acid; TIA, transient ischaemic attack.